Wilk Piotr, Uehlein Monika, Kalms Jacqueline, Dobbek Holger, Mueller Uwe, Weiss Manfred S
Helmholtz-Zentrum Berlin, Macromolecular Crystallography (HZB-MX), Berlin, Germany.
Institut für Biologie, Strukturbiologie/Biochemie, Humboldt-Universität zu Berlin, Germany.
FEBS J. 2017 Sep;284(17):2870-2885. doi: 10.1111/febs.14158. Epub 2017 Aug 8.
Prolidase is a ubiquitously distributed dipeptidase and the only dipeptidase in humans capable of cleaving the peptide bond preceding the amino acids proline (Pro) or hydroxyproline (Hyp). It is mainly implicated in the degradation of dietary and endogenous proteins. It is also involved in the terminal steps of collagen catabolism by hydrolyzing Pro and Hyp-containing dipeptides. Finally, it is believed to play a role in the regulation of peptidic hormones. Diminished or absent prolidase activity is related to a rare autosomal disease, referred to as prolidase deficiency (PD). This disease manifests itself by a variety of clinical symptoms. To date, there is no definitive cure to PD. This may in part be due to an incomplete understanding of the wild-type (wt) enzyme with respect to substrate-binding mode and consequently the mechanism of the catalyzed reaction. In this work, we describe the high-resolution crystal structures of the wt human prolidase in the ligand-free form as well as in substrate-bound states and in complex with the cleavage product Pro. This series of structures provides much relevant information for the definition of substrate-binding and the reaction mechanism. A recent study on Escherichia coli prolidase revealed how substrates of different length are discriminated. Here, based on our own structural results, we evaluate and extend this analysis. Moreover, we describe and analyze substrate and product binding in the active site and we propose that the crucial catalytic moiety is actually a hydroxide ion. This information significantly advances our understanding of prolidase-based pathologies.
The refined structure coordinates as well as the corresponding structure factor amplitudes have been deposited in the PDB under the accession numbers 5M4G, 5M4J, 5M4L, and 5M4Q.
脯氨酰二肽酶是一种广泛分布的二肽酶,也是人类中唯一能够切割脯氨酸(Pro)或羟脯氨酸(Hyp)之前肽键的二肽酶。它主要参与膳食和内源性蛋白质的降解。它还通过水解含Pro和Hyp的二肽参与胶原蛋白分解代谢的终末步骤。最后,据信它在肽类激素的调节中起作用。脯氨酰二肽酶活性降低或缺乏与一种罕见的常染色体疾病有关,称为脯氨酰二肽酶缺乏症(PD)。这种疾病表现为多种临床症状。迄今为止,PD尚无确切的治愈方法。这可能部分是由于对野生型(wt)酶在底物结合模式以及催化反应机制方面的理解不完整。在这项工作中,我们描述了无配体形式以及底物结合状态和与切割产物Pro复合物形式的wt人脯氨酰二肽酶的高分辨率晶体结构。这一系列结构为底物结合和反应机制的定义提供了许多相关信息。最近一项关于大肠杆菌脯氨酰二肽酶的研究揭示了不同长度底物是如何被区分的。在此,基于我们自己的结构结果,我们评估并扩展了这一分析。此外,我们描述并分析了活性位点中的底物和产物结合,并提出关键的催化部分实际上是一个氢氧根离子。这些信息显著推进了我们对基于脯氨酰二肽酶的病理学的理解。
精制后的结构坐标以及相应的结构因子振幅已存入蛋白质数据银行(PDB),登录号为5M4G、5M4J、5M4L和5M4Q。